A population-based cohort study
The use of antipsychotics is known to be high among adults with intellectual and developmental disabilities (IDD) internationally. Long-term use of antipsychotics has been associated with adverse effects and is particularly concerning in adults with IDD because this population has high rates of health issues and may have difficulty reporting side effects.
This study describes factors associated with starting antipsychotics and the patterns of continuing antipsychotic therapy in a large population of adults with IDD.
Access the full article and associated resources:
